ArticleInternational journal of cancer2014

Novel function for the p38-MK2 signaling pathway in circulating CD1c+ (BDCA-1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL-12 whilst suppressing IL-10.

Hester A Franks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.